Chemotherapyimmunotherapy - Study guides, Class notes & Summaries

Verification of Treatment as Planned -vascular access device appropriate for treatment plan -will patient adhere to plan -is the treatment plan appropriate for patient -do additional referals need to be made for treatment -is there evidenced based rationale for treatment -is the drug a vesicant and are there safety precautions in place -is the drug a cumulative lifetime dose limit and is there tracking in place Patient education -assess pt's readiness to learn, health literacy, p...

ONS/ONCC Chemotherapy/Immunotherapy Lesson 14: Administration of Drugs Exam Questions and Answers 100% Pass Verification of Treatment as Planned - Correct Answer ️️ --vascular access device appropriate for treatment plan -will patient adhere to plan -is the treatment plan appropriate for patient -do additional referals need to be made for treatment -is there evidenced based rationale for treatment -is the drug a vesicant and are there safety precautions in place -is the drug a cumu...

ONS/ONCC Chemotherapy/Immunotherapy Lesson 9: Plant Alkaloids Exam Questions and Answers 100% Pass Common plant alkaloids - Correct Answer ️️ -Etoposide Docetaxel Paclitaxel Vinblastine Vinorelbine Vinca Alkaloids - Correct Answer ️️ --e.g. Vincristine, Vinblastine, Vinorelbine -IV ONLY: NEVER intrathecal (DEATH!!) -If administered in a syringe, it must be clearly labeled with IV ONLY label -many guidelines urge diluting vincristine into mini IV drip bag and never use syringe t...

Verification of Treatment as Planned Correct Answer: -vascular access device appropriate for treatment plan -will patient adhere to plan -is the treatment plan appropriate for patient -do additional referals need to be made for treatment -is there evidenced based rationale for treatment -is the drug a vesicant and are there safety precautions in place -is the drug a cumulative lifetime dose limit and is there tracking in place Patient education Correct Answer: -assess pt's readiness t...

Common plant alkaloids Etoposide Docetaxel Paclitaxel Vinblastine Vinorelbine Vinca Alkaloids -e.g. Vincristine, Vinblastine, Vinorelbine -IV ONLY: NEVER intrathecal (DEATH!!) -If administered in a syringe, it must be clearly labeled with IV ONLY label -many guidelines urge diluting vincristine into mini IV drip bag and never use syringe to administer to prevent error Taxanes e.g. paclitaxel, cabazitaxel, docetaxel -IV -significant risk of HSR Paclitaxel -requir...

ONS/ONCC CHEMOTHERAPY/IMMUNOTHERAPY LESSON 11: TARGETED THERAPIES WITH COMPLETE SOLUTIONS 100% ONS/ONCC CHEMOTHERAPY/IMMUNOTHERAPY LESSON 11: TARGETED THERAPIES WITH COMPLETE SOLUTIONS 100%

Common plant alkaloids Correct Answer: Etoposide Docetaxel Paclitaxel Vinblastine Vinorelbine Vinca Alkaloids Correct Answer: -e.g. Vincristine, Vinblastine, Vinorelbine -IV ONLY: NEVER intrathecal (DEATH!!) -If administered in a syringe, it must be clearly labeled with IV ONLY label -many guidelines urge diluting vincristine into mini IV drip bag and never use syringe to administer to prevent error Taxanes 2 Correct Answer: e.g. paclitaxel, cabazitaxel, docetaxel -IV -significa...

ONS/ONCC Chemotherapy/Immunotherapy Lesson 9: Plant Alkaloids Exam Questions and Answers 100% Pass Common plant alkaloids - Correct Answer ️️ -Etoposide Docetaxel Paclitaxel Vinblastine Vinorelbine Vinca Alkaloids - Correct Answer ️️ --e.g. Vincristine, Vinblastine, Vinorelbine -IV ONLY: NEVER intrathecal (DEATH!!) -If administered in a syringe, it must be clearly labeled with IV ONLY label -many guidelines urge diluting vincristine into mini IV drip bag and never use syringe t...

Chemotherapy/Immunotherapy Certificate Course (ONS,ONCC) Exam With 100% Correct Answers

Verification of Treatment as Planned --vascular access device appropriate for treatment plan -will patient adhere to plan -is the treatment plan appropriate for patient -do additional referals need to be made for treatment -is there evidenced based rationale for treatment -is the drug a vesicant and are there safety precautions in place -is the drug a cumulative lifetime dose limit and is there tracking in place